(Q31083661)

English

The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397). (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

quality of life

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

Lesley Fallowfield

6

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Lesley Fallowfield

7

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Richard A. Cowan

object named as

Richard Cowan

3

0 references

Matthew R Sydes

object named as

Matthew Sydes

4

0 references

author name string

Richard J Stephens

1

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

David P Dearnaley

2

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Sharon Naylor

5

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

RT01 collaborators

8

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

publication date

28 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

301-310

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Impact of screening on prostate cancer rates and trends

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Early outcomes of active surveillance for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Hormone therapy for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Prostate cancer and health-related quality of life: a review of the literature.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Quality-of-life outcomes in long-term survivors of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Fatigue in patients with prostate cancer receiving hormone therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

The development of a method for assessing the quality of life of cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Waning sexual function--the most important disease-specific distress for patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Changes in quality of life following treatment for early prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile aids

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

The quality of life of patients with newly diagnosed M1 prostate cancer: experience with EORTC clinical trial 30853.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Health-related quality of life among patients with metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Preferences of healthy men for two different endocrine treatment options offered for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06560.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2006.06560.X

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31083661&oldid=1966890232"